Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works

Effects of torcetrapib in patients at high risk for coronary events

Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · see citing works

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911 · see citing works

Effects of dalcetrapib in patients with a recent acute coronary syndrome

Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022 · see citing works

Effects of anacetrapib in patients with atherosclerotic vascular disease

The HPS3/TIMI55–REVEAL Collaborative Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706444 · Cited by 1,047 · see citing works

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

Nissen, S. E., Tardif, J., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Rużyłło, W., Bachinsky, W., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 964 · see citing works

Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions

Sharrett, A. R., Ballantyne, C. M., Coady, S., HEISS, G. M., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 942 · see citing works

Evacetrapib and cardiovascular outcomes in high-risk vascular disease

Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., Gibson, C. M., Granger, C., Menon, V., Montalescot, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609581 · Cited by 801 · see citing works

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Brugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792 · see citing works

Lipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy

Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.006 · Cited by 735 · see citing works

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., & Ridker, P. M. (2009) · Circulation · doi:10.1161/circulationaha.108.816181 · Cited by 490 · see citing works

Development of a Proton Nuclear Magnetic Resonance Spectroscopic Method for Determining Plasma Lipoprotein Concentrations and Subspecies Distributions from a Single, Rapid Measurement

Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420 · see citing works

Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

Chasman, D. I., Paré, G., Mora, S., Hopewell, J. C., Peloso, G., Clarke, R., Cupples, L. A., Hamsten, A., Kathiresan, S., Mälarstig, A., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000730 · Cited by 337 · see citing works

A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC

Usui, S., Hara, Y., Hosaki, S., & Okazaki, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30123-1 · Cited by 334 · see citing works

ULTRACENTRIFUGAL STUDIES OF LIPOPROTEINS OF HUMAN SERUM

Gofman, J. W., Lindgren, F. T., & Elliott, H. A. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51290-x · Cited by 291 · see citing works

Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma

Huang, R., Silva, R. A. G. D., Jerome, W. G., Kontush, A., Chapman, M. J., Curtiss, L. K., Hodges, T. J., & Davidson, W. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2028 · Cited by 246 · see citing works

The Ultracentrifugal Characterization and Isolation of Human Blood Lipids and Lipoproteins, with Applications to the Study of Atherosclerosis.

Lindgren, F. T., Elliott, H. A., & Gofman, J. W. (1951) · The Journal of Physical Chemistry · doi:10.1021/j150484a010 · Cited by 235 · see citing works

Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy

Otvos, J. D., Jeyarajah, E. J., & Bennett, D. W. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.3.377 · Cited by 232 · see citing works

Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography

Okazaki, M., Usui, S., Ishigami, M., Sakai, N., Nakamura, T., Matsuzawa, Y., & Yamashita, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000155017.60171.88 · Cited by 229 · see citing works

Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia

Liao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A. J., Klein, R. L., & Garvey, W. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.978 · Cited by 218 · see citing works

Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial

Ishibashi, S., Yamashita, S., Arai, H., Araki, E., Yokote, K., Suganami, H., Fruchart, J.-C., & Kodama, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.029 · Cited by 208 · see citing works

Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases

Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0823-5 · Cited by 191 · see citing works

Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial

Ishibashi, S., Arai, H., Yokote, K., Araki, E., Suganami, H., & Yamashita, S. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.10.006 · Cited by 184 · see citing works

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1589 · Cited by 164 · see citing works

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Voight, B. F., Peloso, G. M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M. K., Hindy, G., Hólm, H., Ding, E. L., Johnson, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60312-2 · Cited by 148 · see citing works

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Arai, H., Yamashita, S., Yokote, K., Araki, E., Suganami, H., Ishibashi, S., & on behalf of the K-877 Study Group (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.44412 · Cited by 136 · see citing works

Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia

Arai, H., Yamashita, S., Yokote, K., Araki, E., Suganami, H., & Ishibashi, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.032 · Cited by 124 · see citing works

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices

Cole, T. G., Contois, J. H., Csako, G., McConnell, J. P., Remaley, A. T., Devaraj, S., Hoefner, D. M., Mallory, T., Sethi, A. A., & Warnick, G. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196733 · Cited by 122 · see citing works

Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity

Yamashita, S., Matsuzawa, Y., Okazaki, M., Kako, H., Yasugi, T., Akioka, H., Hirano, K., & Tarui, S. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90094-9 · Cited by 120 · see citing works

Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition

Yamashita, S., Hui, D. Y., Wetterau, J. R., Sprecher, D. L., Harmony, J. A. K., Sakai, N., Matsuzawa, Y., & Tarui, S. (1991) · Metabolism · doi:10.1016/0026-0495(91)90097-g · Cited by 102 · see citing works

Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease

Williams, P. T., Zhao, X.-Q., Marcovina, S. M., Otvos, J. D., Brown, B. G., & Krauss, R. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.034 · Cited by 94 · see citing works

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Soedamah‐Muthu, S. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00428-8 · Cited by 82 · see citing works

High-performance liquid chromatography of serum lipoproteins

Ichiro, H. A. R. A., & Okazaki, M. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29062-x · Cited by 80 · see citing works

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

Yokote, K., Yamashita, S., Arai, H., Araki, E., Suganami, H., & Ishibashi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030706 · Cited by 79 · see citing works

Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using “Spherical Particle Model”

Okazaki, M., & Yamashita, S. (2016) · Journal of Oleo Science · doi:10.5650/jos.ess16020 · Cited by 74 · see citing works

Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome

Kuller, L. H., Grandits, G. A., Cohen, J. D., Neaton, J. D., & Prineas, R. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.001 · Cited by 72 · see citing works

Human serum/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia

Mallol, R., Rodriguez, M. A., Brezmes, J., Masana, L., & Correig, X. (2012) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2012.09.001 · Cited by 68 · see citing works

Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent

Hirowatari, Y., Yoshida, H., Kurosawa, H., Doumitu, K.-I., & Tada, N. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d300003-jlr200 · Cited by 68 · see citing works

Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases

Yamashita, S., Masuda, D., & Matsuzawa, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48918 · Cited by 68 · see citing works

FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver

Papazyan, R., Liu, X., Liu, J., Dong, B., Plummer, E. M., Lewis, R. D., Roth, J. D., & Young, M. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081935 · Cited by 66 · see citing works

Assessment of Between-Instrument Variations in a HPLC Method for Serum Lipoproteins and Its Traceability to Reference Methods for Total Cholesterol and HDL-Cholesterol

Usui, S., Nakamura, M., Jitsukata, K., Nara, M., Hosaki, S., & Okazaki, M. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.1.63 · Cited by 57 · see citing works

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination

Krishna, R., Gheyas, F., Liu, Y., Hagen, D., Walker, B., Chawla, A., Côté, J., Blaustein, R. O., & Gutstein, D. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.700 · Cited by 56 · see citing works

High‐Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory‐Related Events Versus Cardiovascular Events: The Multi‐Ethnic Study of Atherosclerosis

Duprez, D. A., Otvos, J. D., Tracy, R. P., Feingold, K. R., Greenland, P., Gross, M. D., Lima, J. A. C., Mackey, R. H., Neaton, J. D., Sanchez, O. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002295 · Cited by 53 · see citing works

Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia

Yamashita, S., Arai, H., Yokote, K., Araki, E., Suganami, H., & Ishibashi, S. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.06.010 · Cited by 51 · see citing works

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination

Yamashita, S., Arai, H., Yokote, K., Araki, E., Matsushita, M., Nojima, T., Suganami, H., & Ishibashi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225537 · Cited by 48 · see citing works

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study

Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13686 · Cited by 46 · see citing works

VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction

Usui, N., Iwata, K., Miyachi, T., Takagai, S., Wakusawa, K., Nara, T., Tsuchiya, K. J., Matsumoto, K., Kurita, D., Kameno, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102917 · Cited by 45 · see citing works

Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance

Matsuba, I., Matsuba, R., Ishibashi, S., Yamashita, S., Arai, H., Yokote, K., Suganami, H., & Araki, E. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12845 · Cited by 44 · see citing works

Skeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice

Shimba, Y., Togawa, H., Senoo, N., Ikeda, M., Miyoshi, N., Morita, A., & Miura, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40643-1 · Cited by 44 · see citing works

Rapid Analysis of Cholesterol of High Density Lipoprotein and Low Density Lipoprotein in Human Serum by High Performance Liquid Chromatography

Ichiro, H. A. R. A., Okazaki, M., & Ohno, Y. (1980) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132933 · Cited by 41 · see citing works

High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality

Silbernagel, G., Pagel, P., Pfahlert, V., Genser, B., Scharnagl, H., Kleber, M. E., Delgado, G., Ohrui, H., Ritsch, A., Grammer, T. B., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.275636 · Cited by 37 · see citing works

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates

Colvin, P. L., Moriguchi, E. H., Barrett, P. H. R., Parks, J. S., & Rudel, L. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34894-x · Cited by 33 · see citing works

Computerized rapid high resolution quantitative analysis of plasma lipoproteins based upon single vertical spin centrifugation

Cone, J. T., Segrest, J. P., Chung, B. H., Ragland, J. B., Sabesin, S. M., & Glasscock, A. M. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38096-2 · Cited by 32 · see citing works

Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women

Furusyo, N., Ai, M., Okazaki, M., Ikezaki, H., Ihara, T., Hayashi, T., Hiramine, S., Ura, K., Kohzuma, T., Schaefer, E. J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.008 · Cited by 30 · see citing works

Heterogeneity of Human Serum High Density Lipoproteins on High Performance Liquid Chromatography1

Okazaki, M., HAGIWARA, N., & Ichiro, H. A. R. A. (1982) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133959 · Cited by 28 · see citing works

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study

Ide, K., Koshizaka, M., Tokuyama, H., Tokuyama, T., Ishikawa, T., Maezawa, Y., Takemoto, M., & Yokote, K. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0706-8 · Cited by 27 · see citing works

Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes

Kamijo, Y., Ishii, H., Yamamoto, T., Kobayashi, K., Asano, H., Miake, S., Kanda, E., Urata, H., & Yoshida, M. (2019) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551419866811 · Cited by 26 · see citing works

Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies

Segrest, J. P., Cheung, M. C., & Jones, M. K. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m039172 · Cited by 25 · see citing works

Abnormal lipid/lipoprotein metabolism and high plasma testosterone levels in male but not female aromatase-knockout mice

Amano, A., Kondo, Y., Noda, Y., Ohta, M., Kawanishi, N., Machida, S., Mitsuhashi, K., Senmaru, T., Fukui, M., Takaoka, O., et al. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.007 · Cited by 24 · see citing works

Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification

Okazaki, M., Usui, S., Nakamura, M., & Yamashita, S. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.05.008 · Cited by 21 · see citing works

A comparative study of four independent methods to measure LDL particle concentration

Hopkins, P. N., Pottala, J. V., & Nanjee, M. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.042 · Cited by 20 · see citing works

Innovatively Established Analysis Method for Lipoprotein Profiles Based on High-Performance Anion-Exchange Liquid Chromatography

Hirowatari, Y., & Yoshida, H. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17037 · Cited by 19 · see citing works

Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study

Masuda, D., Miyata, Y., Matsui, S., & Yamashita, S. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.014 · Cited by 19 · see citing works

Serum lipoprotein distribution, flotation rates and protein analysis

Lindgren, F. T., FREEMAN, N. K., Ewing, A. M., & Jensen, L. C. (1966) · Journal of the American Oil Chemists Society · doi:10.1007/bf02609674 · Cited by 16 · see citing works

A rapid anion-exchange chromatography for measurement of cholesterol concentrations in five lipoprotein classes and estimation of lipoprotein profiles in male volunteers without overt diseases

Manita, D., Hirowatari, Y., & Yoshida, H. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215584405 · Cited by 16 · see citing works

Decreased Serum HDL3Cholesterol Levels in Cirrhosis of the Liver

Okazaki, M., Ichiro, H. A. R. A., Tanaka, A., Kodama, T., & Yokoyama, S. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042616 · Cited by 16 · see citing works

Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho

Kanda, E., Ai, M., Okazaki, M., Yoshida, M., & Maeda, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166459 · Cited by 16 · see citing works

Effect of partially-abraded brown rice consumption on body weight and the indicators of glucose and lipid metabolism in pre-diabetic adults: A randomized controlled trial

Araki, R., Ushio, R., Fujie, K., Ueyama, Y., Suzuki, H., Nakata, Y., & Hashimoto, K. (2017) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2017.01.015 · Cited by 15 · see citing works

Lipoprotein characterization in Quaker parrots (Myiopsitta monachus) using gel‐permeation high‐performance liquid chromatography

Beaufrère, H., Gardhouse, S. M., & Ammersbach, M. (2020) · Veterinary Clinical Pathology · doi:10.1111/vcp.12895 · Cited by 15 · see citing works

Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency

Okada, T., Ohama, T., Okazaki, M., Kanno, K., Matsuda, H., Sairyo, M., Zhu, Y., Saga, A., Kobayashi, T., Masuda, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190875 · Cited by 13 · see citing works

Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial

Tani, S., Matsuo, R., Yagi, T., & Matsumoto, N. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.011 · Cited by 10 · see citing works

Effects of a sweetpotato protein digest on lipid metabolism in mice administered a high-fat diet

Ishiguro, K., Kurata, R., Shimada, Y., Sameshima, Y., & Kume, T. (2016) · Heliyon · doi:10.1016/j.heliyon.2016.e00201 · Cited by 8 · see citing works

Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study

Tani, S., Yagi, T., Matsuo, R., Kawauchi, K., Atsumi, W., Matsumoto, N., & Okumura, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.06.006 · Cited by 7 · see citing works

Loss of Rab6a in the small intestine causes lipid accumulation and epithelial cell death from lactation

Iwaki, A., Moriwaki, K., Sobajima, T., Taniguchi, M., Yoshimura, S., Kunii, M., Kanda, S., Kamada, Y., Miyoshi, E., & Harada, A. (2020) · The FASEB Journal · doi:10.1096/fj.202000028r · Cited by 5 · see citing works

Verification of Low-Density Lipoprotein Cholesterol Levels Measured by Anion-Exchange High-Performance Liquid Chromatography in Comparison with Beta Quantification Reference Measurement Procedure

Manita, D., Yoshida, H., Koyama, I., Nakamura, M., & Hirowatari, Y. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa144 · Cited by 5 · see citing works

Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles

Kinoshita, C., Nagano, T., Seki, N., Tomita, Y., Sugita, T., Aida, Y., Itagaki, M., Satoh, K., Sutoh, S., Abe, H., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i29.6716 · Cited by 3 · see citing works

Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography

Masuda, D., Kiyosue, A., Hirayama, A., Shimauchi, J., López, J. A. G., Miyawaki, K., & Yamashita, S. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54353 · Cited by 3 · see citing works

Characterization of Lipoprotein Abnormalities in Type III Hyperlipoproteinnemia Associated with Apo E3 Deficiency (E2/2 Phenotype)

Matsuzawa, Y., Noboru, S. H. O., KAMEDA, K., Kubo, M., Hirobe, K., Tarui, S., Yamamoto, A., Okazaki, M., & Ichiro, H. A. R. A. (1984) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.11.6_1243 · Cited by 1 · see citing works

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Das Pradhan, A., Glynn, R. J., Fruchart, J.-C., MacFadyen, J. G., Zaharris, E. S., Everett, B. M., Campbell, S. E., Oshima, R., Amarenco, P., Blom, D. J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2210645 · Cited by 749 · see citing works

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis

Yamashita, S., Rizzo, M., Su, T., & Masuda, D. (2023) · Metabolites · doi:10.3390/metabo13050626 · Cited by 40 · see citing works

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?

Lappegård, K. T., Kjellmo, C. A., & Hovland, A. (2021) · Biomedicines · doi:10.3390/biomedicines9070836 · Cited by 30 · see citing works

The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations

Pikó, P., Kósa, Z., Sándor, J., Seres, I., Paragh, G., & Ádány, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-15192-9 · Cited by 23 · see citing works

Small Remnants versus Large Triglyceride-Rich Lipoproteins in Risk of Atherosclerotic Cardiovascular Disease

Wadström, B. N., Wulff, A. B., Pedersen, K. M., & Nordestgaard, B. G. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae222 · Cited by 12 · see citing works

First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency

Aso, M., Yamamoto, T. T., Kuroda, M., Wada, J., Kubota, Y., Ishikawa, K., Maezawa, Y., Teramoto, N., Tawada, A., Asada, S., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11271 · Cited by 9 · see citing works

Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study

Costacou, T., Miller, R. G., Bornfeldt, K., Heinecke, J. W., Orchard, T. J., & Vaisar, T. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.01.004 · Cited by 10 · see citing works

Lipoprotein‐subclass particle numbers in children with abdominal obesity

Akiyama, H., Iwata, F., & Okada, T. (2021) · Pediatrics International · doi:10.1111/ped.15045 · Cited by 4 · see citing works

Validation by HPLC analyses of new equations for estimating cholesterol in plasma lipoprotein subfractions

Yokoyama, S., Remaley, A. T., Sampson, M. L., Ai, M., & Okazaki, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158986 · Cited by 4 · see citing works

Development of internal standard for lipoprotein subclass analysis using dual detection gel-permeation high-performance liquid chromatography system

Ogino, M., Kameda, T., Mutsuda, Y., Tanaka, H., Takahashi, J., Okazaki, M., Ai, M., & Ohkawa, R. (2022) · Bioscience Reports · doi:10.1042/bsr20220291 · Cited by 3 · see citing works

Effect of pemafibrate on high-density lipoprotein cholesterol levels and subspecies in a patient with cholesteryl ester transfer protein deficiency: A case report with mechanistic insights

Tanigawa, R., Nagai, S., Takahashi, H., Suganami, H., & Yamashita, S. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.07.006 · Cited by 2 · see citing works

Relationship between the cholesterol and triglyceride content of lipoprotein subclasses and carotid intima-media thickness: A cross-sectional population-based study

Ikezaki, H., Furusyo, N., Ai, M., Okazaki, M., Kohzuma, T., Hayashi, J., Shimono, N., & Schaefer, E. J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117521 · Cited by 2 · see citing works

Fluorescence analysis of serum lipoproteins using a histidine-imidazole polyacrylamide slab gel electrophoresis methodPreprint

Takenaka, Y., Inoue, I., Ikeda, M., & Kakinuma, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.26.650752

A Fluorescence-Based Histidine-Imidazole Polyacrylamide Gel Electrophoresis (HI-PAGE) Method for Rapid and Practical Lipoprotein Profiling and LDL-C Quantification in Clinical Samples

Takenaka, Y., Inoue, I., Ikeda, M., & Kakinuma, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13102560

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations

Rief, M., Raggam, R. B., Rief, P., Metnitz, P., Stojaković, T., Reinthaler, M., Brodmann, M., März, W., Scharnagl, H., & Silbernagel, G. (2022) · Biomedicines · doi:10.3390/biomedicines10071766 · Cited by 6 · see citing works

Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

Otvos, J. D. (2002) · PubMed · Cited by 347 · see citing works

A Systematic Approach to Obtain Validated Partial Least Square Models for Predicting Lipoprotein Subclasses from Serum NMR Spectra

Mihaleva, V. V., van Schalkwijk, D. B., de Graaf, A. A., van Duynhoven, J., van Dorsten, F. A., Vervoort, J. J. M., Smilde, A. K., Westerhuis, J. A., & Jacobs, D. M. (2013) · Analytical Chemistry · doi:10.1021/ac402571z · Cited by 39 · see citing works

Additional file 3 of A new phenotypic classification system for dyslipidemias based on the standard lipid panel

Sampson, M. L., Ballout, R. A., Soffer, D., Wolska, A., Wilson, S. R., Meeusen, J., Donato, L. J., Fatica, E. M., Otvos, J. D., Brinton, E. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088214

Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics

Dyrby, M., Petersen, M., Whittaker, A. K., Lambert, L. K., Nørgaard, L., Bro, R., & Engelsen, S. B. (2004) · Analytica Chimica Acta · doi:10.1016/j.aca.2004.10.052 · Cited by 67 · see citing works